Skip to content
★ Sign in to follow
AJ

Anthon Jahreskog

Board Director
Director
BioGaia ABBioGaia AB
Insider activity · 24 months6 buys1 saleCumulative net flow
Total declarations
7
Company
1
▲ Purchases (6 ops.)
€78k
▼ Sales (1 ops.)
€199

Latest filing published 05 Dec 2025 for BioGaia AB, €45k.

Filing timeline

BuySale
Anthon Jahreskog

Insider track record

Disclosed buys
6
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+0.1%

Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Anthon Jahreskog: trading record in brief

Anthon Jahreskog, listed as board member, appears in our data through filings on BioGaia AB shares, published by Finansinspektionen. Between 8 May 2025 and 5 December 2025, the trades on record add up to 7 filings.

Both buying and selling appear: 6 purchases worth €78k, against 1 sale worth €199. Taken together, the purchases exceed the sales by €78k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

In size, the median ticket on the buying side is €7,009. As a share of market capitalisation, the median purchase stands at 0.0007%, based on 6 purchases. Of 6 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 5 December 2025: an open-market purchase of €45k, in BioGaia AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Anthon Jahreskog

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    StyrelseledamotExecutivesBioGaia AB
    €45k23FI-SE
    5,000 shares@ €8.92740.0043% mcap75.8% of flowAktieISIN SE0017769995FI:A003U454-1
    Canonical exit: 5 Mar 2026 (T+90)
  • ▲
    StyrelseledamotExecutivesBioGaia AB
    €13k17FI-SE
    1,380 shares@ €9.18940.0012% mcap21.5% of flowAktieISIN SE0017769995FI:A003U222-1
    Canonical exit: 25 Feb 2026 (T+90)
  • ▲
    StyrelseledamotExecutivesBioGaia AB
    €30712FI-SE
    35 shares@ €8.76910.0000% mcap0.5% of flowAktieISIN SE0017769995FI:A003T395-1
    Canonical exit: 5 Feb 2026 (T+90)
  • ▼
    StyrelseledamotExecutivesBioGaia AB
    €19912FI-SE
    20 shares@ €9.97420.0000% mcap0.3% of flowAktieISIN SE0017769995FI:A003T026-1
  • ▲
    StyrelseledamotExecutivesBioGaia AB
    €1,33616FI-SE
    136 shares@ €9.82280.0001% mcap6.8% of flowAktieISIN SE0017769995FI:A003O451-1
    Canonical exit: 14 Aug 2025 (T+90)
  • ▲
    StyrelseledamotExecutivesBioGaia AB
    €1,08112FI-SE
    112 shares@ €9.64760.0001% mcap1.8% of flowAktieISIN SE0017769995FI:A003O363-1
    Canonical exit: 13 Aug 2025 (T+90)
  • ▲
    StyrelseledamotExecutivesBioGaia AB
    €18k20FI-SE
    2,015 shares@ €9.13930.0018% mcap93.2% of flowAktieISIN SE0017769995FI:A003O021-1
    Canonical exit: 6 Aug 2025 (T+90)

7 of 7 declarations